Yahoo Finance • 8 days ago
CHICAGO, MILWAUKEE and NEW YORK, Sept. 23, 2025 (GLOBE NEWSWIRE) -- YieldMax® ETFs is excited to announce the launch today of the following ETF: YieldMax® HIMS Option Income Strategy ETF (NYSE: HIYY) HIYY seeks to generate current inco... Full story
Yahoo Finance • 10 days ago
Wall Street finished the week on a strong note as all three major market averages tagged record levels on Friday. For the week, the Nasdaq (COMP:IND), S&P 500 (SP500), and Dow (DJI) rose by 2.21%, 1.22%, and 1.05%, respectively. The S&P... Full story
Yahoo Finance • 12 days ago
What Happened? Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 3.5% in the morning session after investors focused on the company's strong growth prospects, which appeared to overshadow recent regulatory challenges. Th... Full story
Yahoo Finance • 13 days ago
US stocks closed mixed on Wednesday after the Federal Reserve ushered in the first US interest rate cut of 2025. Fed officials voted in favor of a 25 basis point reduction, a move highly anticipated by the market, following the central ban... Full story
Yahoo Finance • 14 days ago
US stocks rose on Wednesday after the Federal Reserve ushered in the first US interest rate cut of 2025. Fed officials voted in favor of a 25 basis point reduction, a move highly anticipated by the market, following the central bank's two... Full story
Yahoo Finance • 14 days ago
US stocks were mixed on Wednesday after the Federal Reserve ushered in the first US interest rate cut of 2025. Fed officials voted in favor of a 25 basis point cut, a move highly anticipated by the market, following the central bank's two... Full story
Yahoo Finance • 14 days ago
↗️Hershey (HSY): Shares in the chocolate maker rose 4.3% after Goldman Sachs upgraded its recommendation on the shares to buy from sell. ↘️ Hims & Hers (HIMS): Shares of the telehealth platform dropped 5. Continue Reading View Comments... Full story
Yahoo Finance • 14 days ago
US stocks pulled back from records on Tuesday as the Federal Reserve kicked off its September policy meeting. The benchmark S&P 500 (^GSPC) and the tech-heavy Nasdaq Composite (^IXIC) slipped roughly 0.1%. The Dow Jones Industrial Average... Full story
Yahoo Finance • 14 days ago
Health care stocks were mixed late Tuesday afternoon, with the NYSE Health Care Index adding 0.3% an PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story
Yahoo Finance • 14 days ago
[FDA Headquarters - White Oak Campus] hapabapa The U.S. FDA has issued separate warning letters to Eli Lilly (NYSE:LLY [https://seekingalpha.com/symbol/LLY]) and Novo Nordisk (NVO [https://seekingalpha.com/symbol/NVO]) regarding claims ma... Full story
Yahoo Finance • 15 days ago
LONDON, Sept. 16, 2025 /PRNewswire/ -- Leverage Shares, a pioneer and leading exchange-traded product (ETP) issuer with approximately $1.5 billion in assets under management (AUM) [1], today announces the launch of 19 new ETPs on the Londo... Full story
Yahoo Finance • 15 days ago
Below is Validea's guru fundamental report for HIMS & HERS HEALTH INC (HIMS). Of the 22 guru strategies we follow, HIMS rates highest using our Small-Cap Growth Investor model based on the published strategy of Motley Fool. This strategy... Full story
Yahoo Finance • 16 days ago
Check out some of the companies making the biggest moves midday: Tesla — CEO Elon Musk disclosed he bought $1 billion worth of shares of the electric vehicle maker on Friday, helping send the stock 6% higher. On Semiconductor , Analog Devi... Full story
Yahoo Finance • 16 days ago
Morning Brief host Julie Hyman tracks several of the day's top trending stock tickers, including Tesla (TSLA) CEO Elon Musk's purchase of the EV stock, China's probe into US semiconductors, and the US Food and Drug Administration (FDA) cla... Full story
Yahoo Finance • 16 days ago
Check out the companies making the biggest moves in premarket trading: Tesla -- CEO Elon Musk disclosed he bought $1 billion worth of shares of the EV maker on Friday, helping send the stock nearly 8% higher. Nvidia -- The dominant maker o... Full story
Yahoo Finance • 21 days ago
US President Donald Trump is launching an enforcement drive against pharmaceutical companies and social media influencers who are responsible for “misleading” drug advertising. The US Food and Drug Administration (FDA) is sending thousand... Full story
Yahoo Finance • 21 days ago
[Glass molecular structure] Jonathan Kitchen Hims & Hers Health (NYSE:HIMS [https://seekingalpha.com/symbol/HIMS]) is set to introduce new offerings for men experiencing low testosterone this Wednesday, according to Bloomberg News. The i... Full story
Yahoo Finance • 22 days ago
In recent trading, shares of Hims & Hers Health Inc (Symbol: HIMS) have crossed above the average analyst 12-month target price of $15.18, changing hands for $15.51/share. When a stock reaches the target an analyst has set, the analyst lo... Full story
Yahoo Finance • 26 days ago
[Ozempic Insulin injection pen] CR/iStock via Getty Images The U.S. FDA has begun a crackdown on illegally imported active pharmaceutical ingredients used to make GLP-1 weight loss drugs. Although Novo Nordisk (NVO [https://seekingalpha.... Full story
Yahoo Finance • 27 days ago
We recently published 10 Power Stocks Crushing Wall Street — 7 at All-Time Highs. Hims & Hers Health, Inc. (NYSE:HIMS) is one of the best performers on Wednesday. Hims & Hers snapped a two-day losing streak on Wednesday, adding 7.06 perce... Full story